RDP in the News
October 2, 2023 | Caitlin Oprysko | POLITICO Influence
Feinstein’s successor consulted for Uber, Airbnb
October 1, 2023 | Ann Finkel and Lewis Barnes | Jacobin
We All Live in a Company Town Now. The Labor Movement Can Lead the Way Out.
September 25, 2023 | Jessica Corbett | Common Dreams
'He Cannot Be Trusted': Thomas Urged to Recuse From CFPB Case Over Koch Ties
September 7, 2023 | Maxine Joselow & Vanessa Montalbano | The Washington Post
Why Biden's Methane Fee Could Backfire
September 7, 2023 | Greig Aitken | Global Energy Monitor
Global Energy Monitor Newsletter: Issue 51
September 6, 2023 | Victor Reklaitis | Dow Jones Newsletter
Biden gives pep talk about unions, with UAW strike possible next week
September 6, 2023 | Jake Johnson | Common Dreams
Google Doesn't Want Public to Listen In on Historic Antitrust Trial
September 5, 2023 | Vandana Singh | Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
September 1, 2023 | Spencer Kimball | CNBC
Judge Withdraws From Medicare Drug Price Case After Stock Ownership Is Revealed
September 1, 2023 | Jake Johnson | Common Dreams
Watchdog Calls On Judge With Pharma Investments to Recuse From Drug Pricing Case
August 31, 2023 | Austin Ahlman | The Intercept
After Blocking Lockheed Martin Acquisition, FTC Allows Another Defense Firm To Close The Deal
August 31, 2023 | KPFA | Background Briefing
PODCAST: How Big Pharma With the Help of the Corporate-Friendly Supreme Court Could Kill the Lowering of Drug Prices
August 30, 2023 | Above The Law
Morning Docket: 08.30.23
August 29, 2023 | Yuval Rosenberg & Michael Rainey | The Fiscal Times
Biden Admin Picks First 10 Drugs Targeted for Price Cuts
August 23, 2023 | Ben White | The Messenger